Program Analysis
Starting salaries of $40,141/yr fall 17% below the $48,121 national median for Biotechnology. The financial case depends heavily on whether tuition compensates.
At 9.3x the cost of in-state tuition, the ten-year earnings outlook represents a strong return. Not exceptional, but meaningfully positive.
AI risk is moderate — 48% task exposure — and the 5% scenario spread suggests disruption would dent but not destroy the earnings outlook.
At $18,386 in median debt against $40,141 in first-year earnings, graduates can expect to clear their loan balance in under six months of full earnings.
At #16 out of 18 programs, Colorado State University-Fort Collins's financial outcomes for Biotechnology trail the majority of peers. The value case depends on other factors.